Joyang Laboratories is a finished-dose manufacturer based in China. It holds 9 active US drug master files and 3 valid CEPs across a filed portfolio of 9 molecules. Its GMP standing is certified by MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 25 April 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3008639692 |
| Yancheng, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Fusidic Acid | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Bacitracin | US FDA | 2 |
| Adenosine | US FDA | 1 |
| Cyclosporine | US FDA | 1 |
| Mycophenolate Mofetil | US FDA | 1 |
| Mycophenolic Acid | US FDA | 1 |
| Pioglitazone | US FDA | 1 |
| Sodium Fusidate | EDQM | 1 |
| Tacrolimus | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| MFDS (Korea) | None | 2 |
| US FDA | None | 1 |
Choose your molecules and target markets. Joyang Laboratories comes back tiered against every other supplier able to file there.
Start for free